It is not always possible to reliably estimate the adverse event frequency or establish a causal relationship to product exposure using this data. Not all adverse reactions are reported to FDA CVM. The following adverse events are based on post-approval adverse drug experience reporting. Pre-approval laboratory and clinical studies showed that CAPSTAR Tablets are safe for use in dogs and cats, puppies and kittens 2 pounds of body weight or greater and 4 weeks of age and older. Do not administer to pets under 2 pounds. Weigh your pet prior to administration to ensure proper dosage. DosageĬAPSTAR Tablets should be administered according to the following schedule. Fleas can reproduce on untreated pets and allow infestations to persist. Treat all infested pets in the household. If you are not sure that your pet swallowed the pill, it is safe to give a second pill. If you hide the pill in food, watch closely to make sure your pet swallows the pill. To give CAPSTAR Tablets, place the pill directly in your pet’s mouth or hide it in food. If your pet gets re-infested with fleas, you can safely give another dose as often as once per day. DirectionsĬAPSTAR Tablets kill adult fleas and are indicated for the treatment of flea infestations on dogs, puppies, cats and kittens 2 pounds of body weight or greater and 4 weeks of age and older.Ī single dose of CAPSTAR should kill the adult fleas on your pet. Keep this and all drugs out of the reach of children. Active IngredientsĬAPSTAR Tablets contain 11.4 or 57.0 mg of nitenpyram, which belongs to the chemical class of neonicotinoids. This information is provided as a service to our users.ĬAPSTAR is an oral tablet for dogs, puppies, cats and kittens 2 pounds of body weight or greater and 4 weeks of age and older. Current label information has not been provided by the product owner.
0 Comments
Leave a Reply. |